| Model Number |
1L75-25 |
| Medical Device Problem Code |
Low Test Results (2458)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
07/31/2021
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
No patient identifier or demographic information was provided by the customer.An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
|
| |
|
Event or Problem Description
|
|
The customer identified falsely depressed architect cyclosporine results for one patient the following information was provided: patient history - dosage was 4 tablets, with results 90-110ng/ml for a duration of 10 years.Early (b)(6) 2021, dosage reduced to 3 tablets, results were approximately 50 ng/ml.The customer expected the results to be approximately 67-82 ng/ml.Late (b)(6) 2021 dosage increased to 4 tablets; result approximately 50 ng/ml.The customer expected the results to be 90-110 ng/ml.The patient is performing normally.
|
| |
|
Additional Manufacturer Narrative
|
|
A review of tickets was performed for reagent lot number 22007m800.The ticket search determined that there is normal complaint activity for the reagent lot and issue (falsely depressed results).A review of tracking and trending did not identify any trends for the complaint issue.Return testing was not completed as returns were not available.A retained reagent kit of lot number 22007m800 was tested to evaluate the performance of reagent lot 22007m800 with internal panels.Acceptance criteria were met, which indicated acceptable product performance.A review of the manufacturing documentation did not identify any issues associated with the complaint issue.A review of labeling concluded that the issue is sufficiently addressed.Based on the investigation no systemic issue or deficiency of the architect cyclosporine reagent 22007m800 was identified.
|
| |
|
Search Alerts/Recalls
|